An automated drug discovery method for screening biological activity of large number of compounds against selected target is called as high throughput screening (HTS).
Major factors driving growth of the global high throughput screening (HTS) market are increasing demand for advanced and automated drug discovery techniques from various pharmaceuticals and biochemical companies and increasing investment by government and private players in drug discovery. A major factor hampering growth of the global high throughput screening (HTS) market is high capital investment.
The global market is segmented on the basis of technology, application, end-users, and region. on the basis of technology, the global market is segmented into ultra-high-throughput screening, cell-based assays, lab-on-a-chip, and label-free technology.
On the basis of application, the global market is segmented into drug discovery programs, chemical biology programs, biochemical screening, and cell- & organ-based screening. The drug discovery programs segment is expected to witness highest growth over the next 10 years.
On the basis of end-user, the global market is segmented into pharmaceutical and biotechnology, academia and research institutes, and contract research organization. The pharmaceutical and biotechnology segment accounted for highest revenue share in the global market.
Request for the Sample Report Here: https://marketresearch.biz/report/high-throughput-screening-hts-market/request-sample/
On the basis of region, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America accounts for highest revenue share in the global market, owing to high investments for research & development of new medicine by major players. The Asia pacific high throughput screening market is expected to witness highest growth in terms of revenue during the forecast period.
Key players in the global market are Agilent Technologies Inc., Thermo Fisher Scientific Inc., Axxam SpA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Hamilton Company, PerkinElmer Inc., Danaher Corporation, GE Healthcare, Merck KGaA, Tecan Group Ltd., Aurora Biomed, and other prominent players.